Adherence to perinatal group B streptococcal prevention guidelines

Obstetrics and Gynecology

Volumn 115, Issue 6, 2010, Pages 1217-1224

  Goins, William P ^a   Talbot, Thomas R ^a   Schaffner, William ^a   Edwards, Kathryn M ^a   Craig, Allen S ^a   Schrag, Stephanie J ^a   Van Dyke, Melissa K ^a   Griffin, Marie R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHEMOPROPHYLAXIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INFECTION; INFECTION PREVENTION; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NEWBORN; PATIENT COMPLIANCE; PENICILLIN ALLERGY; PERINATAL PERIOD; POPULATION RESEARCH; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RANDOM SAMPLE; RETROSPECTIVE STUDY; SCREENING; SEROLOGY; UNITED STATES;

ADULT; ANTIBIOTIC PROPHYLAXIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MEDICAL AUDIT; PERINATAL CARE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TENNESSEE; YOUNG ADULT;

EID: 77953016899     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181dd916f     Document Type: Article

References (23)

1. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum che-moprophylaxis. N Engl J Med 1986;314:1665-1669
2. Prevention of perinatal group B streptococcal disease: a public health perspective [published erratum appears in MMWR Morb Mortal Wkly Rep 1996;45:679]. MMWR Recomm Rep 1996;45:1-24.
3. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-239
4. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51:1-22.
5. Eisenberg E, Craig AS, Gautam S, Khalil MM, Shaktour B, Schaffner W, et al. Beyond screening: identifying new barriers to early onset group B streptococcal disease prevention. Pedi-atr Infect Dis J 2005;24:520-524
6. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, et al. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 2001; 7:92-99
7. U.S. Census Bureau. Census 2000 data for the state of Tennessee. Available at: http://www.census.gov/census2000/states/tn.html. Retrieved March 11, 2008.
8. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626-2636
9. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health 1994;84:1414-1420 (Pubitemid 24290938)
10. Fiore Mitchell T, Pearlman MD, Chapman RL, Bhatt-Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001;98:1075-1079
11. Laiprasert J, Klein K, Mueller BA, Pearlman MD. Transpla-cental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol 2007;109:1105-1110
12. Tennessee Department of Health. Number of live births with rates per 1,000 population, by race of mother, for counties of Tennessee, resident data, 2003. Available at: http://health. state.tn.us/statistics/vital.htm. Retrieved May 5, 2008.
13. Tennessee Department of Health. Number of live births with rates per 1,000 population, by race of mother, for counties of Tennessee, resident data, 2004. Available at: http://health. state.tn.us/statistics/vital.htm. Retrieved May 5, 2008.
14. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-1246
15. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-815
16. Matteson KA, Lievense SP, Catanzaro B, Phipps MG. Intra-partum group B streptococci prophylaxis in patients reporting a penicillin allergy. Obstet Gynecol 2008;111:356-364
17. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91:112-114
18. Wakimoto H, Yano H, Baba S, Okuzumi K, Okamoto N, Wakimoto Y, et al. Prevention of vertical transmission of group B streptococcus [Japanese]. Kansenshogaku Zasshi 2005;79: 549-555
19. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184: 1204-1210
20. Sullivan SA, Smith T, Chang E, Hulsey T, Vandorsten JP, Soper D. Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesar-ean infectious morbidity: a randomized, controlled trial. Am J Obstet Gynecol 2007;196:455.e1-5
21. Thigpen BD, Hood WA, Chauhan S, Bufkin L, Bofill J, Magann E, et al. Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial. Am J Obstet Gynecol 2005;192:1864-1868
22. Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother 1985;35:267-280
23. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine 2003;21:3468-3472